StockGuide AI
Track Stocks
EN RU ES
Gallagher

Gallagher

Price: 220.14

Company and Business Model

Gallagher (AJG.US) is a global insurance brokerage and risk management firm. The company provides a range of services including insurance brokerage, employee benefits consulting, and risk management solutions. Its major business segments include retail brokerage, wholesale brokerage, and risk management services. The primary revenue sources are commissions from insurance placements and fees for consulting services. Gallagher operates in various sectors, catering to both commercial and personal insurance needs.

Investment Profile

The investment profile of Gallagher is more aligned with value investors, given its stable revenue growth and moderate dividend yield. The stock may appeal to those seeking consistent performance rather than high growth potential. Its risk profile suggests caution, making it less suitable for aggressive growth strategies. Investors may find it appropriate for a balanced approach, focusing on steady returns over time.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
6.27 OK
Revenue QoQ — quarter-over-quarter revenue growth
31.1% ↑
EPS surprise
1.3% in line
20d volatility
1.9% stable
Dividend yield
1.2% moderate last ex-date: 2026-03-06
FMP / FinFeed data updated: 2026-06-11

Forecast impact

positive
Rating Upgraded · UBS · valid until 2026-07-08 · updated 2026-06-11
Target +13.6% target fill 88.1%
Reaction D5 pending · D10 pending fresh confirmed · market trust
Impact Potential +6 · Risk -3 up to 30 days or until target is reached
Reco: Hold Potential: 67 Risk: 40 Updated: 2026-06-11 05:35
How recommendation works
Why AI thinks so:
Strong revenue growth and positive EPS surprise support bullish outlook.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-05 02:54 Sell Hold Positive momentum but mixed performance signals present risks.
2026-06-01 02:56 Hold Sell Weak momentum and high risk; cautious approach advised.
2026-05-24 02:31 Sell Hold Weak momentum and high risk; cautious approach advised.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-08 20:18 UBS Rating Upgraded — → 250 212.52
2026-05-21 11:55 UBS Target Lowered 265 → 240 203.61
2026-05-07 13:14 Morgan Stanley Target Lowered 275 → 265 202.19